a basic steroid structure. The utility of such steroidal antagonists is limited by their interactions with the receptors of other steroid hormones, which in some cases lead to considerable side effects such as gynecomastia and impotence and to discontinuation of the therapy [M. A. Zaman, S. Opa...
We used G36, a GPR30 antagonist that was recently developed for human cancer research [22], [23], [24] and is known to bind to receptors on bovine satellite cells [25], to test the hypothesis that GPR30 bound with ZEN or one of the five ZEN metabolites suppresses GnRH-induced LH ...